A New Duplication Exon 2 Mouse Model:A Tool for Studies of Duplication Skipping for Duchenne

A New Duplication Exon 2 Mouse Model:

A Tool for Studies of Duplication Skipping for Duchenne

A Webinar with Dr. Kevin Flanigan 

Hosted by

CureDuchenne was pleased to host the “New Duplication Exon 2 Mouse Model: A Tool for Studies of Duplication Skipping for Duchenne” a webinar with Dr. Kevin Flanigan on November 21, 2013.  The webinar was an opportunity for parents to learn about the duplication mutation research and an exciting exon skipping method using AAV delivery with U7 from Dr. Kevin Flanigan at Nationwide Children’s Hospital. CureDuchenne has provided the lead funding for Dr. Flanigan’s duplication research.

Click here to watch the recording of the webinar. You’ll be prompted to enter your name and email address to view the recording.

Our presenters were:

	Kevin M. Flanigan, MD, is an attending neurologist at Nationwide Children’s and Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Flanigan is a principal investigator in the Center for Gene Therapy in The Research Institute at Nationwide Children’s, and a leading expert in Neuromuscular Disorders.
	Michael Kelly, Ph.D., Chief Scientific Officer at CureDuchenne, will moderate the session.